$ALHC

Kent Mark D. purchased $198K of ALHC

Kent Mark D. (President - MSO) purchased 14,848 shares of Alignment Healthcare, Inc. (ALHC) at $13.31 ($0.20M total) on 2026-06-02.

Original reporting
SEC EDGAR · Kent Mark D.
Published Jun 2, 2026, 10:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 2, 2026, 11:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ALHC
Bullish
medium confidence
Mentioned
$ALHC
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALHCBullishLow
01

Why it matters

The disclosure may slightly improve near-term sentiment and can be used as a supportive input for positioning, but it does not change the company’s fundamentals on its own.

02

Market read

A same-day insider open-market buy of ~14,848 shares at ~$13.31/share is a modest positive signal for ALHC sentiment.

03

What to watch

Check whether the officer has a history of buys/sells and whether there are concurrent corporate events (financing, guidance, contracts) not captured in this Form 4.

Relevance 7/10Novelty 6/10Timing: Filed same day as the open-market purchase (2026-06-02).

Background

This is an SEC Form 4 insider transaction disclosure for Alignment Healthcare, Inc., showing an officer/direct purchase.

Company-level read

Ticker impact

$ALHCBullishMedium confidence
Context

Alignment Healthcare officer Kent Mark purchased $197.6K of ALHC shares in an open-market transaction on 2026-06-02.

Expected impact

Likely limited/short-lived impact; any reaction should be small unless accompanied by other news.

Evidence & confidence

The filing provides a concrete buy datapoint (size and date) but no new operational, financial, or deal information; also no 10b5-1 plan is cited.

Market effects

Minimal; this is company-specific insider activity with no sector-wide policy or competitive signal.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine or driven by personal liquidity/tax planning; without broader fundamentals, follow-through may not materialize.

Key entities

  • Alignment Healthcare, Inc.

    Subject of the insider transaction filing (ALHC).

  • Kent Mark

    President - MSO who reported an open-market purchase of ALHC shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ALHCMed

Why Alignment Healthcare (ALHC) Stock Is Up Today

Alignment Healthcare (ALHC) shares rose 8.6% after its subsidiary announced a new Medicare Advantage plan in Los Angeles and Orange counties. Analyst Ryan Langston lowered his price target to $12 but maintained a Buy rating, citing inpatient utilization pressure. The stock had fallen 13.4% the previous day due to a downgrade and regulatory concerns.

$HUMMedAI 8/10

Humana Rebounds in Medicare Advantage Star Ratings for 2027

Humana's Medicare Advantage star ratings improved significantly for 2027, with 93% of members in plans rated 4 stars or higher, up from 41% in 2026. This could generate $3B+ in additional revenue in 2028, according to TD Cowen. Alignment Healthcare saw a major decline, potentially losing $170M in revenue. CMS changed its star ratings methodology for 2027.

$ALHCHigh

ALHC Stock Slides As Legal, Cost, And Rating Pressures Mount

Alignment Healthcare Inc. (ALHC) stock fell 14.75% on October 9, 2026, amid concerns over Medicare Advantage reimbursement pressures, legal issues, and cost challenges. The company reported $1.34B in revenue and $36.6M in net income for the latest quarter, but negative cash flow raised concerns. CMS's 2027 Star Ratings and a whistleblower's accounting allegations further pressured the stock, with Barclays cutting its price target to $10.